Navigation Links
Men Who at Risk Of Developing Prostate Cancer

Men who have a brother with prostate cancer are twice as likely to develop the disease themselves. A new study shows// more men realize this fact and are taking steps to prevent cancer.

A recent study done compared data from two studies, researchers asked men about their risk and, also, if they are currently taking vitamins or supplements to prevent prostate cancer.The first study shows more than half of the 111 men surveyed were concerned about developing the disease. All of the men had a brother who had been diagnosed with prostate cancer. The lifetime risk for men with a brother who has prostate cancer is about 56 percent, suggesting that the men surveyed are accurately accessing their risk.

The second study asked the same group of men about their use of complementary and alternative medicine. More than half said they were taking at least one vitamin or supplement, and 30 percent were using a type of complementary medicine linked to prostate health or prostate cancer prevention.

Thus specialist conclude that patient education programs are working and more people are able to understand the seriousness of the problem.
'"/>




Page: 1

Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Identifying The Risks Of Developing Schizophrenia
6. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
7. Cancer Patients At A Greater Risk Of Developing Blood Clots
8. Young Smokers at Increased Risk Of Developing a Heart Attack
9. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
10. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
11. Risk Of Developing Infections High In Patients Who Suffer From Abdominal Trauma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... its market value in 2016. There are currently three proton therapy centers ... to treat more patients. In Italy , the first ...
(Date:3/29/2017)... 2017  Providence Medical Technology, Inc., an innovator ... two industry veterans to the commercial leadership team.  ... to lead Global Marketing, and Michael Scott ... and Mr. Scott have over 40 years of ... joins the company with over 22 years of ...
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
Breaking Medicine Technology: